Guideline-discordant care in acute myocardial infarction: predictors and outcomes

Pearson, Kristen J

doi:10.5694/j.1326-5377.2002.tb04962.x

Topics

To the Editor: Advocating implementation of evidence-based clinical practice guidelines is one aspect of the current drive to provide quality healthcare across different centres.

Correspondence: dkyong@optusnet.com.au

1. Scott IA, Harper CM. Guideline-discordant care in acute myocardial infarction: predictors and outcomes. Med J Aust 2002; 177: 26-31. <eMJA full text>
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
3. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753-770.
4. Krumholz HM, Murillo JE, Chen J, et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA 1997; 277: 1683-1688.

Online responses are no longer available. Please refer to our instructions for authors page for more information.